1 |
33297669 |
10.3324/haematol.2020.267294 |
2022 |
Phenogenomic heterogeneity of post-transplant plasmablastic lymphomas. |
BRAF |
2 |
34710243 |
10.1002/ajh.26390 |
2022 |
Hairy cell leukemia 2022: Update on diagnosis, risk-stratification, and treatment. |
BRAF |
3 |
34802044 |
10.1038/s41379-021-00954-z |
2022 |
A novel diagnostic approach for the classification of small B-cell lymphoid neoplasms based on the NanoString platform. |
BRAF |
4 |
34952945 |
10.1038/s41379-021-01002-6 |
2022 |
Genomic landscape of Epstein-Barr virus-positive extranodal marginal zone lymphomas of mucosa-associated lymphoid tissue. |
BRAF |
5 |
35064935 |
10.1111/his.14619 |
2022 |
Parallel evolution of two distinct lymphoid proliferations in clonal haematopoiesis. |
BRAF |
6 |
35205796 |
10.3390/cancers14041050 |
2022 |
Immunophenotypic Analysis of Hairy Cell Leukemia (HCL) and Hairy Cell Leukemia-like (HCL-like) Disorders. |
BRAF |
7 |
35234079 |
10.1177/10668969221081432 |
2022 |
Hairy Cell Leukemia-Japanese Variant: Report of a Patient and Literature Review. |
BRAF |
8 |
35356636 |
10.14740/jh942 |
2022 |
Concurrent Presentation of Hairy Cell Leukemia and Mantle Cell Lymphoma (Leukemic Non-Nodal Variant): An Extremely Rare Composite Lymphoma. |
BRAF |
9 |
35359040 |
10.3760/cma.j.cn112151-20211220-00915 |
2022 |
[Clinicopathological features and BRAF V600E and MYD88 L265P mutation status of nodal marginal zone lymphoma]. |
BRAF |
10 |
35363510 |
10.1200/JCO.21.02840 |
2022 |
Phase II Study of Selumetinib in Children and Young Adults With Tumors Harboring Activating Mitogen-Activated Protein Kinase Pathway Genetic Alterations: Arm E of the NCI-COG Pediatric MATCH Trial. |
BRAF |
11 |
35437610 |
10.1007/s00277-022-04795-x |
2022 |
Purine nucleoside analogs plus rituximab are an effective treatment choice for hairy cell leukemia-variant. |
BRAF |
12 |
35450208 |
10.1177/20406207221090886 |
2022 |
Updates in hairy cell leukemia (HCL) and variant-type HCL (HCL-V): rationale for targeted treatments with a focus on ibrutinib. |
BRAF |
13 |
35454811 |
10.3390/cancers14081904 |
2022 |
Deciphering Genetic Alterations of Hairy Cell Leukemia and Hairy Cell Leukemia-like Disorders in 98 Patients. |
BRAF |
14 |
35789115 |
10.1111/his.14718 |
2022 |
Hodgkinoid histiocytosis: an atypical nodal CD30 and S100-positive histiocytosis with eosinophilia. |
BRAF |
15 |
36051021 |
10.1002/jha2.486 |
2022 |
Lymphoma-associated acquired von Willebrand syndrome responsive to splenectomy: A case report. |
BRAF |
16 |
32273478 |
10.3324/haematol.2020.251579 |
2021 |
Genetic lesions in MYC and STAT3 drive oncogenic transcription factor overexpression in plasmablastic lymphoma. |
BRAF |
17 |
32638211 |
10.1007/s12020-020-02411-4 |
2021 |
Diagnostic and prognostic value of a 7-panel mutation testing in thyroid nodules with indeterminate cytology: the SWEETMAC study. |
BRAF |
18 |
32929178 |
10.1038/s41379-020-00673-x |
2021 |
The mutational landscape of histiocytic sarcoma associated with lymphoid malignancy. |
BRAF |
19 |
32970929 |
10.1111/ajco.13449 |
2021 |
Role and mechanism of autophagy-regulating factors in tumorigenesis and drug resistance. |
BRAF |
20 |
33360690 |
10.1016/j.jss.2020.11.012 |
2021 |
Thyroid Cancer Identified After Positron Emission Tomography (PET) Shows Aggressive Histopathology. |
BRAF |
21 |
33506327 |
10.1007/s00428-021-03032-6 |
2021 |
Undifferentiated large cell/rhabdoid carcinoma presenting in the intestines of patients with concurrent or recent non-small cell lung cancer (NSCLC): clinicopathologic and molecular analysis of 14 cases indicates an unusual pattern of dedifferentiated metastases. |
BRAF |
22 |
33676171 |
10.1016/j.anndiagpath.2021.151720 |
2021 |
From the archives of MD Anderson Cancer Center: A case of concurrent follicular lymphoma and Langerhans cell sarcoma with a review of the literature. |
BRAF |
23 |
33685720 |
10.1016/j.pathol.2021.01.002 |
2021 |
New developments in non-Hodgkin lymphoid malignancies. |
BRAF |
24 |
33706747 |
10.1186/s12887-021-02590-7 |
2021 |
Giant congenital nodular melanoma in a newborn: a case report and literature review. |
BRAF |
25 |
33735913 |
10.1182/blood.2020010137 |
2021 |
A rapid genotyping panel for detection of primary central nervous system lymphoma. |
BRAF |
26 |
33777766 |
10.3389/fonc.2021.620435 |
2021 |
Case Report: Multiple Chromosomal Translocations Including Novel CIITA-CREBBP Fusion and Mutations in a Follicular Lymphoma. |
BRAF |
27 |
33895683 |
10.1016/j.ejca.2021.03.026 |
2021 |
Computed tomography-guided biopsy of radiologically unclear lesions in advanced skin cancer: A retrospective analysis of 47 cases. |
BRAF |
28 |
33939500 |
10.1177/10668969211013402 |
2021 |
A Pedigree Analysis and Clonal Correlations of the Coexistence of B-Cell Lymphoma and Histiocytic/Dendritic Cell Tumor. |
BRAF |
29 |
34198843 |
10.3390/ijms22116099 |
2021 |
Molecular Characterization of a Rare Case of Bilateral Vitreoretinal T Cell Lymphoma through Vitreous Liquid Biopsy. |
BRAF |
30 |
34466010 |
10.2147/CCID.S323865 |
2021 |
Reactive Langerhans Cell Proliferation Mimicking Langerhans Cell Histiocytosis in Association with Sézary Syndrome: A Case Report and Literature Review. |
BRAF |
31 |
34570179 |
10.1182/bloodadvances.2021004668 |
2021 |
Mutational patterns and their correlation to CHIP-related mutations and age in hematological malignancies. |
BRAF |
32 |
31439678 |
10.3324/haematol.2019.230375 |
2020 |
Genomic profiling of primary histiocytic sarcoma reveals two molecular subgroups. |
BRAF |
33 |
31924734 |
10.1158/1078-0432.CCR-19-3443 |
2020 |
Trametinib Activity in Patients with Solid Tumors and Lymphomas Harboring BRAF Non-V600 Mutations or Fusions: Results from NCI-MATCH (EAY131). |
BRAF |
34 |
32012328 |
10.1002/hon.2718 |
2020 |
High throughput sequencing reveals high specificity of TNFAIP3 mutations in ocular adnexal marginal zone B-cell lymphomas. |
BRAF |
35 |
32040482 |
10.1371/journal.pone.0227586 |
2020 |
Expression of the muscle-associated gene MYF6 in hairy cell leukemia. |
BRAF |
36 |
32052529 |
10.1111/pin.12909 |
2020 |
Clinicopathological analysis of splenic red pulp low-grade B-cell lymphoma. |
BRAF |
37 |
32458259 |
10.1007/s11033-020-05509-0 |
2020 |
BRAF V600E mutation detection in hairy cell leukemia-utility of archival DNA from bone marrow aspirate/imprint smear and amplification refractory mutation system. |
BRAF |
38 |
32627042 |
10.3892/or.2020.7612 |
2020 |
Proline‑rich polypeptide‑1 decreases cancer stem cell population by targeting BAFF chromatin‑remodeling complexes in human chondrosarcoma JJ012 cells. |
BRAF |
39 |
32764384 |
10.3390/cancers12082182 |
2020 |
Simultaneously Inhibiting BCL2 and MCL1 Is a Therapeutic Option for Patients with Advanced Melanoma. |
BRAF |
40 |
33053749 |
10.3390/cancers12102936 |
2020 |
The In Vitro and In Vivo Anticancer Properties of Chalcone Flavokawain B through Induction of ROS-Mediated Apoptotic and Autophagic Cell Death in Human Melanoma Cells. |
BRAF |
41 |
33162442 |
10.11406/rinketsu.61.1469 |
2020 |
[Marginal zone lymphoma-like primary bone marrow lymphoma with long-term pancytopenia preceding diagnosis]. |
BRAF |
42 |
33297339 |
10.3390/nu12123755 |
2020 |
Gene Expression Alterations Associated with Oleuropein-Induced Antiproliferative Effects and S-Phase Cell Cycle Arrest in Triple-Negative Breast Cancer Cells. |
BRAF |
43 |
33330555 |
10.3389/fmed.2020.594118 |
2020 |
Sarcoidosis and Cancer: A Complex Relationship. |
BRAF |
44 |
30320628 |
10.1097/PAS.0000000000001174 |
2019 |
An Immune Suppression-associated EBV-positive Anaplastic Large Cell Lymphoma With a BRAF V600E Mutation. |
BRAF |
45 |
30586141 |
10.1001/jamadermatol.2018.3662 |
2019 |
Association of the POT1 Germline Missense Variant p.I78T With Familial Melanoma. |
BRAF |
46 |
30611946 |
10.1016/j.wneu.2018.12.128 |
2019 |
The Radiological Imaging Features of Easily Misdiagnosed Epithelioid Glioblastoma in Seven Patients. |
BRAF |
47 |
30623224 |
10.1007/s00347-018-0840-8 |
2019 |
[New molecular pathological strategies for malignant iris tumors]. |
BRAF |
48 |
30653166 |
10.1097/MD.0000000000014180 |
2019 |
Simultaneous Hodgkin lymphoma and BRAFV600E-positive papillary thyroid carcinoma: A case report. |
BRAF |
49 |
30869573 |
10.1089/thy.2018.0511 |
2019 |
Combination Treatment with the BRAF<sup>V600E</sup> Inhibitor Vemurafenib and the BH3 Mimetic Navitoclax for BRAF-Mutant Thyroid Carcinoma. |
BRAF |
50 |
30937513 |
10.1007/s00292-019-0586-3 |
2019 |
[Bronchoalveolar lavage in hairy cell leukemia with pulmonary infiltration]. |
BRAF |
51 |
31172191 |
10.1093/ajcp/aqz056 |
2019 |
Histiocytic Sarcoma Following B-Lymphoblastic Leukemia/Lymphoma. |
BRAF |
52 |
31257073 |
10.1016/j.ccell.2019.05.015 |
2019 |
RAC1<sup>P29S</sup> Induces a Mesenchymal Phenotypic Switch via Serum Response Factor to Promote Melanoma Development and Therapy Resistance. |
BRAF |
53 |
31281144 |
10.11406/rinketsu.60.559 |
2019 |
[Hairy cell leukemia complicated by bone marrow necrosis following cladribine administration]. |
BRAF |
54 |
31317311 |
10.1007/s00428-019-02608-7 |
2019 |
Clonal evolution of chronic lymphocytic leukemia to Langerhans cell histiocytosis: a case report. |
BRAF |
55 |
31354304 |
10.2147/OTT.S202061 |
2019 |
<i>BRAF</i> V600E-positive monomorphic epitheliotropic intestinal T-cell lymphoma complicating the course of hairy cell leukemia. |
BRAF |
56 |
31443309 |
10.3390/medicina55080490 |
2019 |
Malignant Pleural Effusion and Its Current Management: A Review. |
BRAF |
57 |
31447330 |
10.1016/j.lpm.2019.07.026 |
2019 |
[Hairy cell leukemia]. |
BRAF |
58 |
31538423 |
10.3349/ymj.2019.60.10.890 |
2019 |
Hairiness is a Facsimile of Reorganized Cytoskeletons: A Cytopathic Effect of <i>Coxiella burnetii</i>. |
BRAF |
59 |
31591741 |
10.1002/ajh.25653 |
2019 |
Hairy cell leukemia: 2020 update on diagnosis, risk stratification, and treatment. |
BRAF |
60 |
29439113 |
10.1136/gutjnl-2016-312608 |
2018 |
Double somatic mutations in mismatch repair genes are frequent in colorectal cancer after Hodgkin's lymphoma treatment. |
BRAF |
61 |
29556019 |
10.1038/s41375-018-0082-4 |
2018 |
High-throughput sequencing of nodal marginal zone lymphomas identifies recurrent BRAF mutations. |
BRAF |
62 |
29565494 |
10.26355/eurrev_201803_14479 |
2018 |
Long non-coding RNA BANCR indicates poor prognosis for breast cancer and promotes cell proliferation and invasion. |
BRAF |
63 |
29618685 |
10.11406/rinketsu.59.281 |
2018 |
[Splenic diffuse red pulp small B-cell lymphoma diagnosed by splenectomy initially mimicking hairy cell leukemia-Japanese variant]. |
BRAF |
64 |
29702524 |
10.1097/MOH.0000000000000435 |
2018 |
Genetic convergence of rare lymphomas. |
BRAF |
65 |
29708356 |
10.14735/amko2018130 |
2018 |
MAPK/ERK signal pathway alterations in patients with Langerhans Cell Histiocytosis. |
BRAF |
66 |
29846633 |
10.1210/jc.2017-01845 |
2018 |
Methodology, Criteria, and Characterization of Patient-Matched Thyroid Cell Lines and Patient-Derived Tumor Xenografts. |
BRAF |
67 |
29854308 |
10.18632/oncotarget.25209 |
2018 |
Comparative oncology DNA sequencing of canine T cell lymphoma via human hotspot panel. |
BRAF |
68 |
29857068 |
10.1016/j.jid.2018.04.038 |
2018 |
Genomic Analyses Identify Recurrent Alterations in Immune Evasion Genes in Diffuse Large B-Cell Lymphoma, Leg Type. |
BRAF |
69 |
29895903 |
10.1038/s41408-018-0089-0 |
2018 |
Integrated DNA/RNA targeted genomic profiling of diffuse large B-cell lymphoma using a clinical assay. |
BRAF |
70 |
29989027 |
10.18632/oncotarget.25601 |
2018 |
New generation sequencing of targeted genes in the classical and the variant form of hairy cell leukemia highlights mutations in epigenetic regulation genes. |
BRAF |
71 |
30035752 |
10.1097/DAD.0000000000001072 |
2018 |
Langerhans Cell Histiocytosis Associated With Underlying Hematolymphoid Disorders in Adults: Report of 2 Cases and Review of the Literature. |
BRAF |
72 |
30335863 |
10.1371/journal.pone.0206014 |
2018 |
Oncogenic mutations in IKKβ function through global changes induced by K63-linked ubiquitination and result in autocrine stimulation. |
BRAF |
73 |
30474563 |
10.1186/s13000-018-0772-2 |
2018 |
Erdheim Chester disease in a patient with Burkitt lymphoma: a case report and review of literature. |
BRAF |
74 |
26882062 |
10.1097/IOP.0000000000000661 |
2017 |
Comparative Study of Clinical, Pathological, Radiological, and Genetic Features of Patients With Adult Ocular Adnexal Xanthogranulomatous Disease, Erdheim-Chester Disease, and IgG4-Related Disease of the Orbit/Ocular Adnexa. |
BRAF |
75 |
27347751 |
10.1080/10428194.2016.1196813 |
2017 |
Splenic diffuse red pulp lymphoma has a distinct pattern of somatic mutations amongst B-cell malignancies. |
BRAF |
76 |
27910030 |
10.1007/978-1-4939-6703-2_22 |
2017 |
Recurrent Cytogenetic Abnormalities in Non-Hodgkin's Lymphoma and Chronic Lymphocytic Leukemia. |
BRAF |
77 |
28084334 |
10.1038/modpathol.2016.235 |
2017 |
Langerhans cell histiocytosis associated with lymphoma: an incidental finding that is not associated with BRAF or MAP2K1 mutations. |
BRAF |
78 |
28246485 |
10.3748/wjg.v23.i6.1106 |
2017 |
Coexisting tubular adenoma with a neuroendocrine carcinoma of colon allowing early surgical intervention and implicating a shared stem cell origin. |
BRAF |
79 |
28280620 |
10.21037/jgo.2017.01.14 |
2017 |
Potential actionable targets in appendiceal cancer detected by immunohistochemistry, fluorescent in situ hybridization, and mutational analysis. |
BRAF |
80 |
28297625 |
10.1200/JCO.2016.71.1556 |
2017 |
Genomics of Hairy Cell Leukemia. |
BRAF |
81 |
28376906 |
10.1186/s13256-017-1253-z |
2017 |
BRAF <sup>V600E</sup> expression in histiocytic sarcoma associated with splenic marginal zone lymphoma: a case report. |
BRAF |
82 |
28399347 |
10.22608/APO.201710 |
2017 |
Conjunctival Tumors: Review of Clinical Features, Risks, Biomarkers, and Outcomes--The 2017 J. Donald M. Gass Lecture. |
BRAF |
83 |
28592763 |
10.11406/rinketsu.58.480 |
2017 |
Malignant lymphoma: pathophysiology and current therapy. |
BRAF |
84 |
28880462 |
10.1111/cup.13017 |
2017 |
Indeterminate dendritic cell neoplasm of the skin: A 2-case report and review of the literature. |
BRAF |
85 |
28883003 |
10.1158/0008-5472.CAN-16-2691 |
2017 |
Discovery of Human-Similar Gene Fusions in Canine Cancers. |
BRAF |
86 |
28892161 |
10.1002/path.4982 |
2017 |
A gene is known by the company it keeps: enrichment of TNFAIP3 gene aberrations in MALT lymphomas expressing IGHV4-34 antigen receptors. |
BRAF |
87 |
28976960 |
10.1038/nature24037 |
2017 |
Cancer drug addiction is relayed by an ERK2-dependent phenotype switch. |
BRAF |
88 |
29110361 |
10.1002/ajh.24936 |
2017 |
Hairy cell leukemia 2018: Update on diagnosis, risk-stratification, and treatment. |
BRAF |
89 |
26426381 |
10.1097/PAS.0000000000000523 |
2016 |
NOTCH1, TP53, and MAP2K1 Mutations in Splenic Diffuse Red Pulp Small B-cell Lymphoma Are Associated With Progressive Disease. |
BRAF |
90 |
26800678 |
10.1007/s00108-015-0006-6 |
2016 |
[Classification of malignant lymphomas. Current situation]. |
BRAF |
91 |
26868143 |
10.1007/s00428-015-1881-x |
2016 |
CD27-positive hairy cell leukemia-Japanese variant. |
BRAF |
92 |
26941398 |
10.1182/blood-2015-11-680074 |
2016 |
BRAF inhibition in hairy cell leukemia with low-dose vemurafenib. |
BRAF |
93 |
27034005 |
10.18632/oncotarget.8427 |
2016 |
Phospho-proteomic analyses of B-Raf protein complexes reveal new regulatory principles. |
BRAF |
94 |
27121112 |
10.3109/10428194.2016.1173212 |
2016 |
Genetic aberrations in small B-cell lymphomas and leukemias: molecular pathology, clinical relevance and therapeutic targets. |
BRAF |
95 |
27135738 |
10.1038/nm.4092 |
2016 |
An oncogenic Ezh2 mutation induces tumors through global redistribution of histone 3 lysine 27 trimethylation. |
BRAF |
96 |
27149123 |
NA |
2016 |
Flavopiridol Induces Apoptosis via Mitochondrial Pathway in B16F10 Murine Melanoma Cells and a Subcutaneous Melanoma Tumor Model. |
BRAF |
97 |
27275640 |
NA |
2016 |
[Novelties in the diagnostics and therapy of hairy cell leukemia]. |
BRAF |
98 |
27600764 |
10.1038/ncomms12602 |
2016 |
Type II enteropathy-associated T-cell lymphoma features a unique genomic profile with highly recurrent SETD2 alterations. |
BRAF |
99 |
27672108 |
10.1093/annonc/mdw282 |
2016 |
First-in-human phase I study of copanlisib (BAY 80-6946), an intravenous pan-class I phosphatidylinositol 3-kinase inhibitor, in patients with advanced solid tumors and non-Hodgkin's lymphomas. |
BRAF |
100 |
27889782 |
10.1159/000453085 |
2016 |
Molecular Pathology: A Requirement for Precision Medicine in Cancer. |
BRAF |